Mach7 (ASX:M7T) share price stumbles 8% on business update

It's not a good day for the ASX-listed medical imaging company.

| More on:
sad, unhappy medical worker, medical share price fall, drop, decrease,

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Mach7 Technologies Ltd (ASX: M7T) share price has taken a tumble in today's trading session.

Shares in the medical imaging software company have taken a dive after Mach7 released its financial report for the fourth quarter and FY21.

Let's take a look at how Mach7 performed.   

Mach7 reports back-to-back annual profits

Earlier today, Mach7 released its activities report for the fourth quarter and overall FY21.

The company's report highlighted Mach7 recording its highest ever cash receipts. The company recorded a 23% growth in cash receipts over the prior year to $21 million.

As a result, Mach7 reported its second consecutive year of positive operating cashflows. For FY21, the company reported positive operating cash of $1.2 million.

In addition, Mach7 recorded its highest annual sales on record. The company reported a 95% increase in sales to $25.64 million in FY21, bringing the company's customer count to 165.

Mach7 also reported low customer churn, less than 2% for the financial year.

The company also underscored its strong financial position, with Mach7 finishing the year with $18.36 million cash on hand.

Overall, Mach7 expects annual revenue to be in the range of $19 million and $19.5 million. The company noted it will release its audited annual financial report in August.

Looking ahead to FY22, Mach7 expects to see strong double-digit revenue growth (higher than 15%) on FY21's figure.

More on Mach7's performance

Mach7 develops innovative data management solutions for healthcare institutions. The company's revenue is generated through live annual support contracts and monthly subscriptions.

In today's report, Mach7 noted the company is now generating $13.36 million of annual recurring revenue (ARR). The company said its ARR has more than doubled since the previous year where Mach7 reported an ARR of $6.51 million.

In addition, Mach7 noted that ARR will continue to grow as existing customers become fully deployed and new customers license the software.

Mach7 signed several new sales orders, contracts, and contract renewals during the fourth quarter of FY21.

Just yesterday, Mach7 also announced an expansion order from Advocate Aurora Healthcare valued at $4.3 million over 5 years. But it seems investors aren't enthused by today's news.

Snapshot of the Mach7 share price

Despite starting the year relatively strongly, the Mach7 share price has floundered in 2021. Since the start of the year, shares in Mach7 are down 28%.

At the time of writing, the Mach7 share price is trading more than 5% lower for the day at around 91 cents. Shares in the company hit an intra-day low of 87.5 cents earlier, to be down more than 8% for the day.

Motley Fool contributor Nikhil Gangaram has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended MACH7 FPO. The Motley Fool Australia has recommended MACH7 FPO. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

A man clenches his fists in excitement as gold coins fall from the sky.
Broker Notes

These ASX 200 shares can rise 20% to 50%

Let's see which shares are being tipped to rocket from current levels.

Read more »

The silhouettes of ten people holding hands with their arms raised against the sky, as the sun rises or sets in the background.
Share Gainers

Here are the top 10 ASX 200 shares today

Investors panicked when the latest inflation figures came out today.

Read more »

A man holds his head in his hands, despairing at the bad result he's reading on his computer.
Broker Notes

Why Guzman Y Gomez shares are a sell

Goldman Sachs has given its verdict on the burrito seller.

Read more »

A man pulls a shocked expression with mouth wide open as he holds up his laptop.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why Mac Copper, Pro Medicus, Web Travel, and Yancoal shares are pushing higher today

These shares are having a good time on hump day. But why?

Read more »

Frustrated stock trader screaming while looking at mobile phone, symbolising a falling share price.
Share Fallers

Why ALS, Fisher & Paykel Healthcare, IPD, and Predictive Discovery shares are falling today

These shares are having a tough time on hump day. But why?

Read more »

Man looking at his grocery receipt, symbolising inflation.
Share Market News

How are ASX 200 investors responding to the latest Aussie inflation numbers?

The ASX 200 was up 0.2% today before the ABS reported the latest inflation figures.

Read more »

A couple makes silly chip moustache faces and take a selfie on their phone.
Broker Notes

Macquarie sees more upside in Telstra shares – What are they worth?

Telstra shares are up 34% over the past year, and Macquarie thinks there's more to come.

Read more »